Allergy & Immunology

Question 1

Describe the type of patient who receives a tetanus-diphtheria toxoid booster after developing a penetrating wound.

Answer 1

1. Patients with severe or dirty wounds who received a booster = 5 years prior
2. Patients with a clean wound who received a booster =10 years prior

Question 2

Describe the type of patient who should receive tetanus immune globulin (TIG) after developing a penetrating wound.

Answer 2

Patients who have a severe or dirty wound AND an unclear or incomplete vaccination history.

• You may also give TIG to patients who are significantly immunocompromised or unimmunized.